Transforming activities of JC virus early proteins

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 288-309

  Frisque, Richard J ^a   Hofstetter, Catherine ^a   Tyagarajan, Shiva K ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; VIRUS T ANTIGEN;

ANIMAL; CHEMISTRY; GENETICS; HUMAN; JC VIRUS; METABOLISM; PHYSIOLOGY; REVIEW; VIRUS CELL TRANSFORMATION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; JC VIRUS;

EID: 33745590910     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_21     Document Type: Review

References (125)

1. Frisque RJ, White III FA. The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. In: Roos RP, ed. Molecular Neurovirology. Totowa, NJ: Humana Press; 1992:25-158.
2. Vilchez RA, Butel JS. Polyomavirus SV40 infection and lymphomas in Spain. Int J Cancer 2003; 107(3):505-506.
3. Carbone M, Bocchetta M, Cristaudo A et al. SV40 and human brain tumors. Int J Cancer 2003; 106(1):140-142.
4. Garcea RL, Imperiale MJ. Simian virus 40 infection of humans. J Virol 2003; 77(9):5039-5045.
5. Atwood WJ. Genotypes, archetypes, and tandem repeats in the molecular epidemiology and pathogenesis of JC virus induced disease. J Neurovirol 2003; 9(5):519-521.
6. Seth P, Diaz F, Major EO. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J Neurovirol 2003; 9(2):236-246.
7. Yang B, Prayson RA. Expression of Bax, Bcl-2, and p53 in progressive multifocal leukoencephalopathy. Mod Pathol 2000; 13(10):1115-1120.
8. Richardson-Burns SM, Kleinschmidt-DeMasters BK, DeBiasi RL et al. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol 2002; 59(12):1930-1936.
9. Hirsch HH, Steiger J, Polyomavirus BK. Lancet Infect Dis 2003; 3(10):611-623.
10. Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene 2002; 21(8):1141-1149.
11. Vilchez RA, Madden CR, Kozinetz CA et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359(9309):817-823.
12. Del Valle L, Baehring J, Lorenzana C et al. Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas. J Clin Pathol-Mol Pathol 2001; 54(5):331-337.
13. Laghi L, Randolph AE, Chauhan DP et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 1999; 96:7484-7489.
14. Zambrano A, Kalantari M, Simoneau A et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53(4):263-276.
15. Small JA, Scangos GA, Cork L et al. The early region of human papovavirus JC induces dysmyelination in transgenic mice. Cell 1986; 46:13-18.
16. Trapp BD, Small JA, Pulley M et al. Dysmyelination in transgenic mice containing JC virus early region. Ann Neurol 1988; 23(1):38-48.
17. Haas S, Haque NS, Beggs AH et al. Expression of the myeHn basic protein gene in transgenic mice expressing human neurotropic virus, JCV, early protein. Virology 1994; 202(1):89-96.
18. Horvath CJ, Simon MA, Bergsagel DJ et al. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. Am J Pathol 1992; 140(6):1431-1440.
19. Eddy BE, Borman GS, Berkeley WH et al. Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 1961; 107:191-197.
20. Jensen PN, Major EO. Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J Leuk Biol 1999; 65(4):428-438.
21. Bollag B, Chuke W-F, Frisque RJ. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: Identification of sequences important for efficient transformation. J Virol 1989; 63:863-872.
22. Trowbridge PW, Frisque RJ. Analysis of G418-selected Rat2 cells containing prototype, variant, mutant, and chimeric JC-virus and SV40 genomes. Virology 1993; 196(2):458-474.
23. Safak M, Khalili K. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J Neurovirol 2001; 7(4):288-292.
24. Darbinyan A, Darbinian N, Safak M et al. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002; 21(36):5574-5581.
25. Barbaro BA, Sreekumar KR, Winters DR et al. Phosphorylation of simian virus 40 T antigen on Thr 124 selectively promotes double-hexamer formation on subfragments of the viral core origin. J Virol 2000; 74(18):8601-8613.
26. Hübner S, Xiao C-Y, Jans DA. The protein kinase CK2 site (Ser111/112) enhances recognition of the simian virus 40 large T-antigen nuclear localization sequence by importin. J Biol Chem 1997; 272(27):17191-17195.
27. Prives C. The replication functions of SV40 T antigen are regulated by phosphorylation. Cell 1990; 61:735-738.
28. Fanning E. Control of SV40 DNA replication by protein phosphorylation: a model for cellular DNA rephcation? Trends Cell Biol 1994; 4(7):250-255.
29. Nesper J, Smith RWP, Kautz AR et al. A cell-free replication system for human polyomavirus JC DNA. J Virol 1997; 71 (10):7421-7428.
30. Lynch KJ, Frisque RJ. Identification of critical elements within the JC virus DNA replication origin. J Virol 1990; 64:5812-5822.
31. Sock E, Wegner M, Grummt F. DNA replication of human polyomavirus-JC is stimulated by NF-I in vivo. Virology 1991; 182(1):298-308.
32. Sock E, Wegner M, Fortunato EA et al. Large T-antigen and sequences within the regulatory region of JC virus both contribute to the features of JC virus DNA replication. Virology 1993; 197(2):537-548.
33. Tada H, Lashgari MS, Khalili K. Regulation of JCVL promoter function: evidence that a pentanucleotide "silencer" repeat sequence AGGGAAGGGA down-regulates transcription of the JC virus late promoter. Virology 1991; 180:327-338.
34. Chang CF, Tada H, Khalili K. The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. Gene 1994; 148(2):309-314.
35. Chen L, Joo WS, Bullock PA et al. The N-terminal side of the origin-binding domain of simian virus 40 large T antigen is involved in A/T untwisting. J Virol 1997; 71(11):8743-8749.
36. San Martin MC, Gruss C, Carazo JM. Six molecules of SV40 large T antigen assemble in a propeller-shaped particle around a channel. J Mol Biol 1997; 268:15-20.
37. Valle M, Gruss C, Halmer L et al. Large T-antigen double hcxamers imaged at the simian virus 40 origin of replication. Mol Cell Biol 2000; 20(1):34-41.
38. Ishimi Y, Sugasawa K, Hanaoka F et al. Topoisomerase-II plays an essential role as a swivelase in the late stage of SV40 chromosome replication in vitro. J Biol Chem 1992; 267(1):462-466.
39. Kim HY, Ahn BY, Cho Y. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J 2001; 20(1-2):295-304.
40. Lynch KJ, Haggerty S, Frisque RJ. DNA replication of chimeric JC virus-simian virus 40 genomes. Virology 1994; 204:819-822.
41. Smith RW, Nasheuer HP. Initiation of JC virus DNA replication in vitro by human and mouse DNA polymerase alpha-primase. Eur J Biochem 2003; 270(9):2030-2037.
42. Dornreiter I, Hoss A, Arthur AK et al. SV40 T antigen binds directly to the large subunit of purified DNA polymerase alpha. EMBO J 1990; 9:3329-3336.
43. Murakami Y, Eki T, Yamada M et al. Species-specific in vitro synthesis of DNA containing the polyoma virus origin of replication. Proc Natl Acad Sci USA 1986; 83:6347-6351.
44. Srinivasan A, McClcllan AJ, Vartikar J et al. The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol 1997; 17(8):4761-4773.
45. DeCaprio JA. The role of the J domain of SV40 large T in cellular transformation. Biologicals 1999; 27(1):23-28.
46. Sheng Q, Denis D, Ratnofsky M et al. The DnaJ domain of polyomavirus large T is required to regulate RB family tumor suppressor function. J Virol 1997; 71(12):9410-9416.
47. Zhu XY, Ohtsubo M, Bohmer RM et al. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 1996; 133(2):391-403.
48. Sullivan CS, Cantalupo P, Pipas JM. The molecular chaperone activity of simian virus 40 large T antigen is required to disrupt Rb-E2F family complexes by an ATP-dependent mechanism. Mol Cell Biol 2000; 20(17):6233-6243.
49. Sullivan CS, Pipas JM. The virus-chaperone connection. Virology 2001; 287(1):1-8.
50. Sullivan CS, Tremblay JD, Fewell SW et al. Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40. Mol Cell Biol 2000; 20(15):5749-5757.
51. Sullivan CS, Gilbert SP, Pipas JM. ATP-dependent simian virus 40 T-antigen-Hsc70 complex formation. J Virol 2001; 75:1601-1610.
52. Sullivan CS, Pipas JM. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Micro Mol Biol Rev 2002; 66(2):179-202.
53. Frisque RJ, Rifkin DB, Walker DL. Transformation of primary hamster brain cells with JC virus and its DNA. J Virol 1980; 35:265-269.
54. Tiemann F, Zerrahn J, Deppert W. Cooperation of simian virus 40 large and small T antigens in metaboHc stabiUzation of tumor suppressor p53 during cellular transformation. J Virol 1995; 69(10):6115-6121.
55. Tavis JE, Trowbridge PW, Frisque RJ. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's Umited transforming activity but does eHminate viral viability. Virology 1994; 199:384-392.
56. Dyson N, Buchkovich K, Whyte P et al. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 1989; 58(2):249-255.
57. Dyson N, Bernards R, Friend SH et al. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 1990; 64:1353-1356.
58. Bollag B, Prins C, Snyder EL et al. Purified JC virus T and T′ proteins differentially interact with the retinoblastoma family of tumor suppressor proteins. Virology 2000; 274:165-178.
59. Howard CM, Claudio PP, De Luca A et al. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27(Kjp1), and cyclin E negative feedback regulatory loop. Cancer Res 2000; 60(10):2737-2744.
60. Chuke WF, Walker DL, Peitzman LB et al. Construction and characterization of hybrid polyomavirus genomes. J Virol 1986; 60:960-971.
61. Haggerty S, Walker DL, Frisque RJ. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J Virol 1989; 63(5):2180-2190.
62. O'Neill FJ, Frisque RJ, Xu XL et al. Immortalization of human cells by mutant and chimeric primate polyomavirus T-antigen genes. Oncogene 1995; 10(6):1131-1139.
63. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003; 1653(1):1-24.
64. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003; 94(3):225-229.
65. Gan DD, Reiss K, Carrill T et al. Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus. Oncogene 2001; 20(35):4864-4870.
66. Enam S, Del Valle L, Lara C et al. Association of human polyomavirus JCV with colon cancer: Evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 2002; 62(23):7093-7101.
67. Morin PJ. beta-catenin signaling and cancer. Bioessays 1999; 21(12):1021-1030.
68. Dobbie Z, Muller PY, Heinimann K et al. Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicam. Anticancer Res 2002; 22(4):2215-2220.
69. Del Valle L, Wang JY, Lassak A et al. Insulin-like growth factor I receptor signaling system in JC virus T antigen-induced primitive neuroectodermal tumors-meduUoblastomas. J Neurovirol 2002; 8:138-147.
70. Lassak A, Del Valle L, Peruzzi F et al. Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem 2002; 277(19):17231-17238.
71. Theile M, Grabowski G. Mutagenic activity of BKV and JCV in human and other mammalian cells. Arch Virol 1990; 113:221-233.
72. Ray FA, Peabody DS, Cooper JL et al. SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts. J Cell Biochem 1990; 42(1):13-31.
73. Neel JV, Major EO, Awa AA et al. Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implications for oncogenesis. Proc Natl Acad Sci USA 1996; 93(7):2690-2695.
74. Croul S, Otte J, Khalili K. Brain tumors and polyomaviruses. J Neurovirol 2003; 9(2):173-182.
75. Ricciardiello L, Baglioni M, Giovannini C et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003; 63(21):7256-7262.
76. Renner K, Leger H, Wegner M. The POU domain protein Tst-1 and papovaviral large tumor antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc Natl Acad Sci, USA 1994; 91(l4):6433-6437.
77. Gruda MC, Zabolotny JM, Xiao JH et al. Transcriptional activation by simian virus-40 large T-antigen - interactions with multiple components of the transcription complex. Mol Cell Biol 1993; 13(2):961-969.
78. Gallia GL, Safak M, Khalili K. Interaction of the single-stranded DNA-binding protein Pur alpha with the human polyomavirus JC virus early protein T-antigen. J Biol Chem 1998; 273(49):32662-32669.
79. Chen NN, Khalili K. Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur α in glial cells. J Virol 1995; 69(9):5843-5848.
80. Safak M, Gallia GL, Ansari SA et al. Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 1999; 73:10146-10157.
81. Kerr D, Chang CF, Chen NC et al. Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 1994; 68(11):7637-7643.
82. Safak R, Gallia GL, Khalili K. Reciprocal interaction between two cellular proteins, Pur alpha and YB-1, modulates transcriptional activity of JCV(CY) in glial cells. Mol Cell Biol 1999; 19(4):2712-2723.
83. Chen NN, Chang CF, Gallia GL et al. Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci USA 1995; 92(4):1087-1091.
84. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4(5):E131-136.
85. Amemiya K, Traub R, Durham L et al. Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 1989; 264(12):7025-7032.
86. Sadowska B, Barrucco R, Khalili K et al. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 2003; 77(l):665-672.
87. Kim J, Woolridge S, Biffi R et al. Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol 2003; 77(9):5241-5252.
88. Carswell S, Alwine JC. Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J Virol 1986; 60:1055-1061.
89. Ng S-C, Mertz JE, Sanden-Will S et al. Simian virus 40 maturation in cells harboring mutants deleted in the agnogene. J Biol Chem 1985; 260:1127-1132.
90. Resnick J, Shenk T. Simian virus 40 agnoprotein facilitates normal nuclear location of the major capsid polypeptide and cell to cell spread of virus. J Virol 1986; 60:1098-1106.
91. Del Valle L, Gordon J, Enam S et al. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst 2002; 94(4):267-273.
92. Safak M, Barrucco R, Darbinyan A et al. Interaction of JC virus Agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J Virol 2001; 75(3):1476-1486.
93. Safak M, Sadowska B, Barrucco R et al. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol 2002; 76(8):3828-3838.
94. Shenk T, Carbon J, Berg P. Construction and analysis of viable deletion mutants of simian virus 40. J Virol 1976; 18:664-671.
95. Mandl C, Walker DL, Frisque RJ. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J Virol 1987; 61:755-763.
96. Topp WC. Variable defectiveness for lytic growth of the dl 54/59 mutants of simian virus. J Virol 1980; 33:1208-1210.
97. Martin RG, Setlow VP, Edwards CAF et al. The roles of the simian virus 40 tumor antigens in transformation of Chinese hamster lung cells. Cell 1979; 17:635-643.
98. Frisque RJ, Rifkin DB, Topp WC. Requirement for the large T and small T proteins of SV40 in the maintenance of the transformed state. CSH Symp Quant Biol 1980; 44:325-331.
99. Sleigh MJ, Topp WC, Hanish R et al. Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell 1978; 14:79-88.
100. Bikel I, Montano X, Agha ME et al. SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell 1987; 48:321-330.
101. Porras A, Bennett J, Howe A et al. A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J Virol 1996; 70:6902-6908.
102. Yu J, Boyapati A, Rundell K. Critical role for SV40 small-t antigen in human cell transformation. Virology 2001; 290(2):192-198.
103. Hahn WC, Dessain SK, Brooks MW et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22(10):3562-3562.
104. Rundell K, Parakati R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 2001; 11(1):5-13.
105. Genevaux P, Lang F, Schwager F et al. Simian virus 40 T antigens and J domains: Analysis of Hsp40 cochaperone functions in Escherichia coH. J Virol 2003; 77(19):10706-10713.
106. Watanabe G, Howe A, Lee RJ et al. Induction of cyclin Dl by simian virus 40 small tumor antigen. Proc Natl Acad Sci, USA 1996; 93(23):12861-12866.
107. Rundell K. Complete interaction of cellular 56,000- and 32,000-Mr proteins with simian virus 40 small-t antigen in productively infected cells. J Virol 1987; 61:1240-1243.
108. Mungre S, Enderle K, Turk B et al. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation. J Virol 1994; 68(3):1675-1681.
109. Garcia A, Cereghini S, Sontag E. Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters. J Biol Chem 2000; 275(13):9385-9389.
110. Yang SI, Lickteig RL, Estes R et al. Control of protein phosphatase-2A by simian virus-40 small-t antigen. Mol Cell Biol 1991; 11(4):1988-1995.
111. Yuan H, Veldman T, Rundell K et al. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 2002; 76(21):10685-10691.
112. Gaillard S, Fahrbach KM, Parkati R et al. Overexpression of simian virus 40 small-t antigen blocks centrosome function and mitotic progression in human fibroblasts. J Virol 2001; 75(20):9799-9807.
113. Yan Y, Shay JW, Wright WE et al. Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation. J Biol Chem 1997; 272(24):15220-15226.
114. Zerrahn J, Tiemann F, Deppert W. Simian virus 40 small t antigen activates the carboxy-terminal transforming p53-binding domain of large T antigen. J Virol 1996; 70(10):6781-6789.
115. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol 1984; 51:458-469.
116. Trowbridge PW, Frisque RJ. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 1995; 1:195-206.
117. Zerrahn J, Deppert W. Analysis of simian virus-40 small-t antigen-induced progression of rat F111 cells minimally transformed by large-T antigen. J Virol 1993; 67(3): 1555-1563.
118. Riley MI, Yoo W, Mda NY et al. Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain. J Virol 1997; 71:6068-6074.
119. Frisque RJ. Structure and function of JC virus T′ proteins. J Neurovirol 2001; 7(4):293-297.
120. Frisque RJ, Bollag B, Tyagarajan SK et al. T′ proteins influence JC virus biology. J Neurovirol 2003; 9 Suppl 1:15-20.
121. Swenson JJ, Frisque RJ. Biochemical characterization and localization of JC virus large T antigen phosphorylation domains. Virology 1995; 212:295-308.
122. Prins CF, Frisque RJ. JC virus T′ proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells. J Neurovirol 2001; 7(3):250-264.
123. Gjoerup O, Zaveri D, Roberts TM. Induction of p53-independent apoptosis by simian virus 40 small t antigen. J Virol 2001; 75(19):9142-9155.
124. Boyapati A, Wilson M, Yu J et al. SV40 17kT antigen complements dnaj mutations in large T antigen to restore transformation of primary human fibroblasts. Virology 2003; 315(1):148-158.
125. Zerrahn J, Knippschild U, Winkler T et al. Independent expression of the transforming amino-terminal domain of SV40 large T-antigen from an alternatively spliced third SV40 early messenger RNA. EMBO J 1993; 12(12):4739-4746.